내가 좋아할 만한 콘텐츠
New vaccine formulation to improve antigen presentation bit.ly/4758e2O @WeillCornell
⚾ Three strikes and the tumor is out (hey - it's baseball playoff time) - Triple ICB enhances TCR-engineered cell therapy bit.ly/46SKayI
Esperanza para las inmunodeficiencias primarias🔬🩸 👉🏻Una terapia experimental salva la vida de más de medio centenar de niños con una enfermedad letal. Léelo en @el_pais elpais.com/ciencia/2025-1…
Parte del grupo @CNIOStopCancer en el #ASEICACongress, con las pilas científicas recargadísimas! @ASEICAnews
🎯Buscamos #TecnicoAnatomiaPatologica en @PazAresLab con experiencia en IHQ, procesado de muestras FFPE, frescas y biopsia líquida. Toda la info ⬇️
🔝Great discussions in #aseicacongress 🔴 T-cell activation in NSCLC 🔵 TLS structures in SCLC 🟡 Chemoresistance in SCLC @UAI_imas12 @CNIOStopCancer @CIBER_ISCIII @unicomplutense
People at #ASEICACongress ‼️ Visit our poster #149 and find out our last findings in SCLC immune microenvironment. Tomorrow morning session 🤙🏼🤙🏼 #ASEICACongress @PazAresLab @SOSCLC_AECC @CmIlung
Our REPAIRome study finally out today in @ScienceMagazine !!! science.org/doi/10.1126/sc…
🚀 First-time a drug improves OS after 1L platinum-based chemotherapy in #SCLC and breaks the 12 months OS in maintenance setting. 💊 Lurbinectedin + atezolizumab is now @US_FDA approved. 💪 Another step forward! #LCSM @SclcSMASHERS @PhrmMar fda.gov/drugs/resource…
A new Science #Immunology study describes a potent interleukin-21 mimic that can stimulate cytotoxic T cells and shows strong #antitumor activity in mouse models of cancer and in tumor explants derived from patients with #melanoma. scim.ag/3KsvCy9
A new Science #Immunology Review discusses the nuances of #cancer immunotherapies that target inhibitory #ImmuneCheckpoints and examines avenues for improved strategies and outcomes. @VeilletteAndre scim.ag/4myNhBy
💚Ayer Rita, Pablo e Irene participaton en la noche de los investigadores 💚 Por un futuro con ciencia e investigación🔬🧬 @CNIOStopCancer @unicomplutense @UAI_imas12 @CIBER_ISCIII
Case series of tumor lysis syndrome with the bispecific T-cell engager tarlatamab in patients with small cell lung cancer @ClinicalLung. I have not seen this myself, but for various reasons, tarlatamab in #SCLC could be better with lower disease burden. clinical-lung-cancer.com/article/S1525-…
Interested in tertiary lymphoid structures (TLSs)? Check out our latest review, where we chart how TLSs form across organs and contexts — from lung to liver, CNS, skin, gut & more — and their dual roles in protection vs. pathology. Fun collaboration with the Linterman lab. Huge…
Mismatch Repair Deficiency: From DNA repair failure to immunotherapy sensitivity 🌊 Loss of MMR → microsatellite instability → hypermutation → abundant neoantigens 🛡️ Immune context: TIL-rich & inflamed, but immune checkpoints (PD-1, CTLA4, LAG3) and fibrotic stroma…
🗣️Entrevista a Ángel Carracedo, coordinador de #IMPaCTGenómica en @radio5_rne 🔗rtve.es/play/audios/a-… Genómica de precisión equitativa para el diagnóstico de #enfermedadesraras y #cánceres hereditarios🔬 #CIBER
We are seeking a motivated candidates to apply for the next AECC calls and join our team at INIBIC/CHUAC (A Coruña): contraelcancer.es/es/area-invest… @chuaconco, @charocampelo, @fertorresandon
📢¿Eres paciente, familiar o parte de una asociación? Webinario #IMPaCTGenómica para pacientes ⬇️ 🗓️ Lunes 29/09 | ⏰ 17:30 📍 Online | Inscripción obligatoria 🔗forms.office.com/pages/response…
#ScienceSaturday ❓Why are naked mole-rats so resistant to cancer, and what can that teach us about human tumors? ➡️ In a new study, @LabKissil (@MoffittNews) and colleagues developed the first lung cancer model in naked mole-rats where tumors formed inside the animals’ own…
United States 트렌드
- 1. South Carolina 16.1K posts
- 2. Bama 13.7K posts
- 3. #HalloweenHavoc 14.6K posts
- 4. Mississippi State 4,143 posts
- 5. #RollTide 4,227 posts
- 6. Vandy 9,645 posts
- 7. Mizzou 7,245 posts
- 8. #VERZUZ 1,387 posts
- 9. Marcel Reed N/A
- 10. Gane 130K posts
- 11. Texas 134K posts
- 12. Arch 20.1K posts
- 13. Jon Jones 13.1K posts
- 14. #UFC321 115K posts
- 15. Ryan Niblett 1,391 posts
- 16. Aspinall 118K posts
- 17. Iowa State 5,755 posts
- 18. Sellers 12.7K posts
- 19. Sark 5,645 posts
- 20. #HookEm 1,983 posts
내가 좋아할 만한 콘텐츠
-
Luis Paz-Ares
@LuisPaz_Ares -
ASEICA
@ASEICAnews -
Xose R Bustelo
@XRBustelo -
María Abad
@MariaAbadMendez -
Casanova Acebes Lab
@Casanova_Acebes -
Guillermo de Cárcer
@GdC_CCCB_lab -
Fundación Fero
@FundacionFero -
Noemi Reguart
@NReguart -
Cancer Immunology Research
@CIR_AACR -
Manuel Valiente
@valientelab -
Nature Metabolism
@NatMetabolism -
Hector Peinado
@hps2002 -
David Olmos
@Dolmos77 -
Ana Ortega Molina
@AnaOrtegaMolin1 -
Oded Rechavi
@OdedRechavi
Something went wrong.
Something went wrong.